The polymorphic acetylation of sulphapyridine in man.

Heinz C. Schröder, David A. Evans

Journal of Medical Genetics · 1972 · 65 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

Since 1941 salicyl-azo-sulphapyridine (sulphasa- lazaline) has been used in the treatment of ulcerative colitis The drug undergoes exten- sive cleavage of the azo linkage in vivo (Svartz, Kallner, and Helander, 1945; Bottiger and Mollerberg, 1959; Schroder and Campbell, 1971) and the sulphapyridine thus formed is subject to N4-acety- lation and simultaneous ring hydroxylation. The hydroxylated metabolite is recovered in the urine entirely as its 0-glucuronide. The absence of free hydroxylated sulphapyridine in urine indicates that the hydroxylation is the rate-determining step in the formation of the glucuronide (Schr6der and Campbell, 1971). The disposition of sulphapyri- dine in man is shown in Fig. GU1 SULPHAPYRIDINE

References

7